Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Arrhythmias

  Free Subscription


Articles published in J Am Coll Cardiol

Retrieve available abstracts of 162 articles:
HTML format
Text format



Single Articles


    February 2019
  1. DIENER HC, Hart RG, Koudstaal PJ, Lane DA, et al
    Atrial Fibrillation and Cognitive Function: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2019;73:612-619.
    PubMed     Text format     Abstract available


    January 2019
  2. BORGER MA, Mansour MC, Levine RA
    Atrial Fibrillation and Mitral Valve Prolapse: Time to Intervene?
    J Am Coll Cardiol. 2019;73:275-277.
    PubMed     Text format    


  3. GRIGIONI F, Benfari G, Vanoverschelde JL, Tribouilloy C, et al
    Long-Term Implications of Atrial Fibrillation in Patients With Degenerative Mitral Regurgitation.
    J Am Coll Cardiol. 2019;73:264-274.
    PubMed     Text format     Abstract available


  4. JANUARY CT, Wann LS, Calkins H, Chen LY, et al
    2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Hea
    J Am Coll Cardiol. 2019 Jan 21. pii: S0735-1097(19)30209.
    PubMed     Text format    


    December 2018
  5. AUFFRET V, Martins RP, Daubert C, Leclercq C, et al
    Idiopathic/Iatrogenic Left Bundle Branch Block-Induced Reversible Left Ventricle Dysfunction: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2018;72:3177-3188.
    PubMed     Text format     Abstract available


  6. ARNOLD AD, Shun-Shin MJ, Keene D, Howard JP, et al
    His Resynchronization Versus Biventricular Pacing in Patients With Heart Failure and Left Bundle Branch Block.
    J Am Coll Cardiol. 2018;72:3112-3122.
    PubMed     Text format     Abstract available


  7. FAUCHIER L, Cinaud A, Brigadeau F, Lepillier A, et al
    Left Atrial Appendage Closure in Atrial Fibrillation.
    J Am Coll Cardiol. 2018;72:2806-2807.
    PubMed     Text format    


    November 2018
  8. LIN YC, Chien LN, Huang CY
    Reply: Optimal Dose of Rivaroxaban in Asians With Atrial Fibrillation: Further Studies Are Warranted.
    J Am Coll Cardiol. 2018;72:2682-2683.
    PubMed     Text format    


  9. HUANG Y, Mai L, Zhang Y, Cai X, et al
    Optimal Dose of Rivaroxaban in Asians With Atrial Fibrillation: Further Studies Are Warranted.
    J Am Coll Cardiol. 2018;72:2681-2682.
    PubMed     Text format    


  10. KIRCHHOF P, Bach M, Camm AJ
    Reply: Anticoagulants for Cardioembolism Prevention in Atrial Fibrillation Patients: Potential Bias From Real-World Studies.
    J Am Coll Cardiol. 2018;72:2546-2547.
    PubMed     Text format    


  11. LI HF, Hong Y
    Anticoagulants for Cardioembolism Prevention in Atrial Fibrillation Patients: Potential Bias From Real-World Studies.
    J Am Coll Cardiol. 2018;72:2545-2546.
    PubMed     Text format    


  12. JUNG H, Sung JH, Yang PS, Jang E, et al
    Stroke Risk Stratification for Atrial Fibrillation Patients With Hypertrophic Cardiomyopathy.
    J Am Coll Cardiol. 2018;72:2409-2411.
    PubMed     Text format    


  13. LINZ D, Brooks AG, Elliott AD, Kalman JM, et al
    Nightly Variation in Sleep Apnea Severity as Atrial Fibrillation Risk.
    J Am Coll Cardiol. 2018;72:2406-2407.
    PubMed     Text format    


    October 2018
  14. KUSUMOTO FM, Schoenfeld MH, Barrett C, Edgerton JR, et al
    2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guideli
    J Am Coll Cardiol. 2018 Oct 31. pii: S0735-1097(18)38984.
    PubMed     Text format    


  15. KUSUMOTO FM, Schoenfeld MH, Barrett C, Edgerton JR, et al
    2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart R
    J Am Coll Cardiol. 2018 Oct 31. pii: S0735-1097(18)38985.
    PubMed     Text format    


  16. SLOTWINER DJ, Raitt MH, Del-Carpio Munoz F, Mulpuru SK, et al
    Impact of Physiologic Pacing Versus Right Ventricular Pacing Among Patients With Left Ventricular Ejection Fraction Greater Than 35%: A Systematic Review for the 2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia
    J Am Coll Cardiol. 2018 Oct 31. pii: S0735-1097(18)38988.
    PubMed     Text format     Abstract available


  17. CURTIS AB, Khan HA
    Should All Atrial Fibrillation Be Considered a Life-Long Problem Requiring Prophylaxis Against Thromboembolism?
    J Am Coll Cardiol. 2018;72:2037-2039.
    PubMed     Text format    


  18. BUTT JH, Olesen JB, Havers-Borgersen E, Gundlund A, et al
    Risk of Thromboembolism Associated With Atrial Fibrillation Following Noncardiac Surgery.
    J Am Coll Cardiol. 2018;72:2027-2036.
    PubMed     Text format     Abstract available


  19. CHEN ST, Melloni C
    Atrial Fibrillation in Cancer Patients: Recognizing Gaps in Care.
    J Am Coll Cardiol. 2018;72:1923-1925.
    PubMed     Text format    


  20. O'NEAL WT, Claxton JS, Sandesara PB, MacLehose RF, et al
    Provider Specialty, Anticoagulation, and Stroke Risk in Patients With Atrial Fibrillation and Cancer.
    J Am Coll Cardiol. 2018;72:1913-1922.
    PubMed     Text format     Abstract available


  21. SINDET-PEDERSEN C, Lamberts M, Staerk L, Nissen Bonde A, et al
    Combining Oral Anticoagulants With Platelet Inhibitors in Patients With Atrial Fibrillation and Coronary Disease.
    J Am Coll Cardiol. 2018;72:1790-1800.
    PubMed     Text format     Abstract available


    September 2018
  22. CORBALAN R, Nicolau JC, Lopez-Sendon J, Garcia-Castillo A, et al
    Edoxaban Versus Warfarin in Latin American Patients With Atrial Fibrillation: The ENGAGE AF-TIMI 48 Trial.
    J Am Coll Cardiol. 2018;72:1466-1475.
    PubMed     Text format     Abstract available


  23. BUMGARNER JM, Lambert CT, Tarakji KG
    Reply: The Smartwatch Will See You Now: Implications of Mass Screening for Atrial Fibrillation.
    J Am Coll Cardiol. 2018;72:1434-1435.
    PubMed     Text format    


  24. GIANCATERINO SK, Hsu JC
    The Smartwatch Will See You Now: Implications of Mass Screening for Atrial Fibrillation.
    J Am Coll Cardiol. 2018;72:1433-1434.
    PubMed     Text format    


  25. BONDE AN, Staerk L, Lee CJ, Vinding NE, et al
    Outcomes Among Patients With Atrial Fibrillation and Appropriate Anticoagulation Control.
    J Am Coll Cardiol. 2018;72:1357-1365.
    PubMed     Text format     Abstract available


  26. TURAGAM MK, Vuddanda V, Verberkmoes N, Ohtsuka T, et al
    Epicardial Left Atrial Appendage Exclusion Reduces Blood Pressure in Patients With Atrial Fibrillation and Hypertension.
    J Am Coll Cardiol. 2018;72:1346-1353.
    PubMed     Text format     Abstract available


  27. KIM D, Yang PS, Kim TH, Jang E, et al
    Ideal Blood Pressure in Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2018;72:1233-1245.
    PubMed     Text format     Abstract available


    August 2018
  28. STEENSIG K, Olesen KKW, Thim T, Nielsen JC, et al
    Coronary artery disease is independent risk factor for stroke among patients with atrial fibrillation.
    J Am Coll Cardiol. 2018 Aug 23. pii: S0735-1097(18)36961.
    PubMed     Text format    


  29. LEE SR, Choi EK, Han KD, Jung JH, et al
    Edoxaban in Asian Patients With Atrial Fibrillation: Effectiveness and Safety.
    J Am Coll Cardiol. 2018;72:838-853.
    PubMed     Text format     Abstract available


  30. GANDJBAKHCH E, Redheuil A, Pousset F, Charron P, et al
    Clinical Diagnosis, Imaging, and Genetics of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2018;72:784-804.
    PubMed     Text format     Abstract available


  31. COOKE JP, Sukhovershin RA
    Novel Markers for Adverse Events in Atrial Fibrillation.
    J Am Coll Cardiol. 2018;72:734-737.
    PubMed     Text format    


  32. HOROWITZ JD, De Caterina R, Heresztyn T, Alexander JH, et al
    Asymmetric and Symmetric Dimethylarginine Predict Outcomes in Patients With Atrial Fibrillation: An ARISTOTLE Substudy.
    J Am Coll Cardiol. 2018;72:721-733.
    PubMed     Text format     Abstract available


  33. GUHA A, Derbala MH, Zhao Q, Wiczer TE, et al
    Ventricular Arrhythmias Following Ibrutinib Initiation for Lymphoid Malignancies.
    J Am Coll Cardiol. 2018;72:697-698.
    PubMed     Text format    


  34. ALBERT CM
    Ranolazine in Patients With Implantable Cardioverter-Defibrillators: Ready for Prime Time?
    J Am Coll Cardiol. 2018;72:646-649.
    PubMed     Text format    


    July 2018
  35. LIN YC, Chien SC, Hsieh YC, Shih CM, et al
    Effectiveness and Safety of Standard- and Low-Dose Rivaroxaban in Asians With Atrial Fibrillation.
    J Am Coll Cardiol. 2018;72:477-485.
    PubMed     Text format     Abstract available


  36. FAUCHIER L, Cinaud A, Brigadeau F, Lepillier A, et al
    Reply: Device-Related Thrombus After Percutaneous Left Atrial Appendage Occlusion in Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2018;72:474-475.
    PubMed     Text format    


  37. KEA B, Lin AL, Olshansky B, Malveau S, et al
    Stroke Prophylaxis After a New Emergency Department Diagnosis of Atrial Fibrillation.
    J Am Coll Cardiol. 2018;72:471-472.
    PubMed     Text format    


  38. RENDA G, De Caterina R
    Sex Implications in the Response to Anticoagulant Therapy in Atrial Fibrillation.
    J Am Coll Cardiol. 2018;72:283-286.
    PubMed     Text format    


  39. LAW SWY, Lau WCY, Wong ICK, Lip GYH, et al
    Sex-Based Differences in Outcomes of Oral Anticoagulation in Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2018;72:271-282.
    PubMed     Text format     Abstract available


  40. KENT AP, Brueckmann M, Fraessdorf M, Connolly SJ, et al
    Concomitant Oral Anticoagulant and Nonsteroidal Anti-Inflammatory Drug Therapy in Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2018;72:255-267.
    PubMed     Text format     Abstract available


  41. HEALEY JS
    Stroke Prevention in Atrial Fibrillation: What Is Real World, and What Do Real-World Data Reveal?
    J Am Coll Cardiol. 2018;72:154-155.
    PubMed     Text format    


  42. LEE CJ, Gerds TA, Carlson N, Bonde AN, et al
    Risk of Myocardial Infarction in Anticoagulated Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2018;72:17-26.
    PubMed     Text format     Abstract available


  43. LOPES RD, Rordorf R, De Ferrari GM, Leonardi S, et al
    Reply: Digoxin Use in Atrial Fibrillation: Minimizing and Refining its Use When Still Needed.
    J Am Coll Cardiol. 2018;72:125-126.
    PubMed     Text format    


    June 2018
  44. ALKHOULI M, Noseworthy PA, Rihal CS, Holmes DR Jr, et al
    Stroke Prevention in Nonvalvular Atrial Fibrillation: A Stakeholder Perspective.
    J Am Coll Cardiol. 2018;71:2790-2801.
    PubMed     Text format     Abstract available


  45. MCCONNELL MV, Turakhia MP, Harrington RA, King AC, et al
    Mobile Health Advances in Physical Activity, Fitness, and Atrial Fibrillation: Moving Hearts.
    J Am Coll Cardiol. 2018;71:2691-2701.
    PubMed     Text format     Abstract available


  46. GLOTZER TV
    The Cacophony of Silent Atrial Fibrillation.
    J Am Coll Cardiol. 2018;71:2612-2615.
    PubMed     Text format    


  47. WONG JA, Conen D, Van Gelder IC, McIntyre WF, et al
    Progression of Device-Detected Subclinical Atrial Fibrillation and the Risk of Heart Failure.
    J Am Coll Cardiol. 2018;71:2603-2611.
    PubMed     Text format     Abstract available


    May 2018
  48. MELA T
    Smartwatches in the Fight Against Atrial Fibrillation: The Little Watch That Could.
    J Am Coll Cardiol. 2018;71:2389-2391.
    PubMed     Text format    


  49. SZE E, Daubert JP
    Reply: Early Cardiac Resynchronization Therapy for Left Bundle Branch Block-Associated Cardiomyopathies.
    J Am Coll Cardiol. 2018;71:1945-1946.
    PubMed     Text format    


  50. WANG NC, Adelstein EC, Singh M, Voigt AH, et al
    Left Bundle Branch Block-Associated Cardiomyopathies and Early Cardiac Resynchronization Therapy: Conceptualizing a Tailored Approach.
    J Am Coll Cardiol. 2018;71:1943-1944.
    PubMed     Text format    


  51. CHATZIDOU S, Kontogiannis C, Tsilimigras DI, Georgiopoulos G, et al
    Propranolol Versus Metoprolol for Treatment of Electrical Storm in Patients With Implantable Cardioverter-Defibrillator.
    J Am Coll Cardiol. 2018;71:1897-1906.
    PubMed     Text format     Abstract available


    April 2018
  52. GRACE AA, Matthews GDK
    Phenotypic Landscape and Risk Management in Long QT Syndrome: Nudging Forward.
    J Am Coll Cardiol. 2018;71:1672-1675.
    PubMed     Text format    


  53. MAZZANTI A, Maragna R, Vacanti G, Monteforte N, et al
    Interplay Between Genetic Substrate, QTc Duration, and Arrhythmia Risk in Patients With Long QT Syndrome.
    J Am Coll Cardiol. 2018;71:1663-1671.
    PubMed     Text format     Abstract available


  54. FAUCHIER L, Cinaud A, Brigadeau F, Lepillier A, et al
    Device-Related Thrombosis After Percutaneous Left Atrial Appendage Occlusion for Atrial Fibrillation.
    J Am Coll Cardiol. 2018;71:1528-1536.
    PubMed     Text format     Abstract available


  55. YU L, Zhou L, Meng G, Jiang H, et al
    Reply: Optogenetic Neuromodulation of Stellate Ganglia for Patients With Ventricular Arrhythmias, Atrial Fibrillation, Angina, and Takotsubo?
    J Am Coll Cardiol. 2018;71:1496-1497.
    PubMed     Text format    


  56. MADIAS JE
    Optogenetic Neuromodulation of Stellate Ganglia for Patients With Ventricular Arrhythmias, Atrial Fibrillation, Angina, and Takotsubo?
    J Am Coll Cardiol. 2018;71:1495-1496.
    PubMed     Text format    


    March 2018
  57. PRABHU S, Kistler PM
    Reply: Beyond Pulmonary Vein Isolation During Catheter Ablation in Atrial Fibrillation and Systolic Dysfunction.
    J Am Coll Cardiol. 2018;71:1293-1294.
    PubMed     Text format    


  58. ALDAAS OM, Padwal J, Hsu JC
    Beyond Pulmonary Vein Isolation During Catheter Ablation in Atrial Fibrillation and Systolic Dysfunction.
    J Am Coll Cardiol. 2018;71:1292-1293.
    PubMed     Text format    


  59. TURAKHIA MP
    Digoxin in Atrial Fibrillation?: Leave it Out of the Medicine Cabinet.
    J Am Coll Cardiol. 2018;71:1075-1077.
    PubMed     Text format    


  60. LOPES RD, Rordorf R, De Ferrari GM, Leonardi S, et al
    Digoxin and Mortality in Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2018;71:1063-1074.
    PubMed     Text format     Abstract available


  61. BUMGARNER JM, Lambert CT, Hussein AA, Cantillon DJ, et al
    Automated Atrial Fibrillation Detection Algorithm Using Smartwatch Technology.
    J Am Coll Cardiol. 2018 Mar 7. pii: S0735-1097(18)33486.
    PubMed     Text format     Abstract available


  62. KING JB, Marrouche N
    Reply: What Is the Biological Relationship Between Left Atrial Fibrosis and Stroke in Atrial Fibrillation?
    J Am Coll Cardiol. 2018;71:1054-1056.
    PubMed     Text format    


  63. REN JF, Callans DJ, Marchlinski FE
    What Is the Biological Relationship Between Left Atrial Fibrosis and Stroke in Atrial Fibrillation?
    J Am Coll Cardiol. 2018;71:1053-1054.
    PubMed     Text format    


    February 2018
  64. VERMA A, Bhatt DL, Verma S
    Long-Term Outcomes of Post-Operative Atrial Fibrillation: Guilty as Charged.
    J Am Coll Cardiol. 2018;71:749-751.
    PubMed     Text format    


  65. KOSMIDOU I, Chen S, Kappetein AP, Serruys PW, et al
    New-Onset Atrial Fibrillation After PCI or CABG for Left Main Disease: The EXCEL Trial.
    J Am Coll Cardiol. 2018;71:739-748.
    PubMed     Text format     Abstract available


  66. FERREIRA JP, Girerd N, Gregson J, Latar I, et al
    Stroke Risk in Patients With Reduced Ejection Fraction After Myocardial Infarction Without Atrial Fibrillation.
    J Am Coll Cardiol. 2018;71:727-735.
    PubMed     Text format     Abstract available


    January 2018
  67. LINDE C, Braunschweig F
    Cardiomyopathy and Left Bundle Branch Block: A Farewell to Drugs?
    J Am Coll Cardiol. 2018;71:318-320.
    PubMed     Text format    


  68. SZE E, Samad Z, Dunning A, Campbell KB, et al
    Impaired Recovery of Left Ventricular Function in Patients With Cardiomyopathy and Left Bundle Branch Block.
    J Am Coll Cardiol. 2018;71:306-317.
    PubMed     Text format     Abstract available


  69. SHIN JI, Luo S, Alexander GC, Inker LA, et al
    Direct Oral Anticoagulants and Risk of Acute Kidney Injury in Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2018;71:251-252.
    PubMed     Text format    


  70. GONZALEZ CORCIA MC, Sieira J, Pappaert G, de Asmundis C, et al
    Implantable Cardioverter-Defibrillators in Children and Adolescents With Brugada Syndrome.
    J Am Coll Cardiol. 2018;71:148-157.
    PubMed     Text format     Abstract available


  71. GAGE BF
    Stroke Prediction Rules in Atrial Fibrillation.
    J Am Coll Cardiol. 2018;71:133-134.
    PubMed     Text format    


  72. CHAO TF, Lip GYH, Liu CJ, Lin YJ, et al
    Relationship of Aging and Incident Comorbidities to Stroke Risk in Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2018;71:122-132.
    PubMed     Text format     Abstract available


    December 2017
  73. KABIR RA, Doytchinova A, Liu X, Adams D, et al
    Crescendo Skin Sympathetic Nerve Activity and Ventricular Arrhythmia.
    J Am Coll Cardiol. 2017;70:3201-3202.
    PubMed     Text format    


  74. BRUGADA P
    Short QT Syndrome and Hydroquinidine: Rare Diseases and Unavailable Drugs.
    J Am Coll Cardiol. 2017;70:3016-3017.
    PubMed     Text format    


  75. MAZZANTI A, Maragna R, Vacanti G, Kostopoulou A, et al
    Hydroquinidine Prevents Life-Threatening Arrhythmic Events in Patients With Short QT Syndrome.
    J Am Coll Cardiol. 2017;70:3010-3015.
    PubMed     Text format     Abstract available


  76. REDDY VY, Doshi SK, Kar S, Gibson DN, et al
    5-Year Outcomes After Left Atrial Appendage Closure: From the PREVAIL and PROTECT AF Trials.
    J Am Coll Cardiol. 2017;70:2964-2975.
    PubMed     Text format     Abstract available


  77. KHAIRY P
    Reply: Atrial Fibrillation: The Next Epidemic for Patients With Congenital Heart Disease.
    J Am Coll Cardiol. 2017;70:2950-2951.
    PubMed     Text format    


  78. TEUWEN CP, de Groot NMS
    Atrial Fibrillation: The Next Epidemic for Patients With Congenital Heart Disease.
    J Am Coll Cardiol. 2017;70:2949-2950.
    PubMed     Text format    


  79. SANDERS P, Elliott AD, Linz D
    Upstream Targets to Treat Atrial Fibrillation.
    J Am Coll Cardiol. 2017;70:2906-2908.
    PubMed     Text format    


  80. TAKEMOTO Y, Ramirez RJ, Kaur K, Salvador-Montanes O, et al
    Eplerenone Reduces Atrial Fibrillation Burden Without Preventing Atrial Electrical Remodeling.
    J Am Coll Cardiol. 2017;70:2893-2905.
    PubMed     Text format     Abstract available


  81. DUKKIPATI SR, Koruth JS, Choudry S, Miller MA, et al
    Catheter Ablation of Ventricular Tachycardia in Structural Heart Disease: Indications, Strategies, and Outcomes-Part II.
    J Am Coll Cardiol. 2017;70:2924-2941.
    PubMed     Text format     Abstract available


  82. DUKKIPATI SR, Choudry S, Koruth JS, Miller MA, et al
    Catheter Ablation of Ventricular Tachycardia in Structurally Normal Hearts: Indications, Strategies, and Outcomes-Part I.
    J Am Coll Cardiol. 2017;70:2909-2923.
    PubMed     Text format     Abstract available


  83. YU L, Zhou L, Cao G, Po SS, et al
    Optogenetic Modulation of Cardiac Sympathetic Nerve Activity to Prevent Ventricular Arrhythmias.
    J Am Coll Cardiol. 2017;70:2778-2790.
    PubMed     Text format     Abstract available


    November 2017
  84. YAO X, Shah ND, Sangaralingham LR, Gersh BJ, et al
    Reply: NOAC Dosing in Patients With Atrial Fibrillation and Renal Dysfunction.
    J Am Coll Cardiol. 2017;70:2734-2735.
    PubMed     Text format    


  85. SHROFF GR
    NOAC Dosing in Atrial Fibrillation and Renal Dysfunction: What Measure Are You Using?
    J Am Coll Cardiol. 2017;70:2733-2734.
    PubMed     Text format    


  86. HUSSAIN A, Jain SK, Wang NC
    Improved Outcomes With Cardiology Care in Newly Diagnosed Atrial Fibrillation: Is Tachycardia-Induced Cardiomyopathy Underestimated?
    J Am Coll Cardiol. 2017;70:2730.
    PubMed     Text format    


  87. PERINO AC, Turakhia MP
    Reply: Improved Outcomes With Cardiology Care in Newly Diagnosed Atrial Fibrillation: Is Tachycardia-Induced Cardiomyopathy Underestimated?
    J Am Coll Cardiol. 2017;70:2730-2731.
    PubMed     Text format    


  88. WALSH M, Connolly SJ
    Another Dimension of Safety in the Prescription of Anticoagulants for Nonvalvular Atrial Fibrillation.
    J Am Coll Cardiol. 2017;70:2633-2635.
    PubMed     Text format    


  89. YAO X, Tangri N, Gersh BJ, Sangaralingham LR, et al
    Renal Outcomes in Anticoagulated Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2017;70:2621-2632.
    PubMed     Text format     Abstract available


  90. MOGENSEN UM, Jhund PS, Abraham WT, Desai AS, et al
    Type of Atrial Fibrillation and Outcomes in Patients With Heart Failure and Reduced Ejection Fraction.
    J Am Coll Cardiol. 2017;70:2490-2500.
    PubMed     Text format     Abstract available


    October 2017
  91. ABU-OMAR Y, Thorpe BS, Freeman C, Mills C, et al
    Recovery of Left Atrial Contractile Function After Maze Surgery in Persistent Longstanding Atrial Fibrillation.
    J Am Coll Cardiol. 2017;70:2309-2311.
    PubMed     Text format    


  92. AL-KHATIB SM, Stevenson WG, Ackerman MJ, Bryant WJ, et al
    2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the
    J Am Coll Cardiol. 2017 Oct 25. pii: S0735-1097(17)41306.
    PubMed     Text format    


  93. MILAN D
    The Com-PLEC-sity of Atrial Fibrillation Genetics.
    J Am Coll Cardiol. 2017;70:2169-2170.
    PubMed     Text format    


  94. THOROLFSDOTTIR RB, Sveinbjornsson G, Sulem P, Helgadottir A, et al
    A Missense Variant in PLEC Increases Risk of Atrial Fibrillation.
    J Am Coll Cardiol. 2017;70:2157-2168.
    PubMed     Text format     Abstract available


  95. KUSUMOTO FM, Bailey KR, Chaouki AS, Deshmukh AJ, et al
    Systematic Review for the 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical P
    J Am Coll Cardiol. 2017 Oct 24. pii: S0735-1097(17)41304.
    PubMed     Text format     Abstract available


  96. AL-KHATIB SM, Stevenson WG, Ackerman MJ, Bryant WJ, et al
    2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice
    J Am Coll Cardiol. 2017 Oct 24. pii: S0735-1097(17)41305.
    PubMed     Text format    


  97. LAVIE CJ, Pandey A, Lau DH, Alpert MA, et al
    Obesity and Atrial Fibrillation Prevalence, Pathogenesis, and Prognosis: Effects of Weight Loss and Exercise.
    J Am Coll Cardiol. 2017;70:2022-2035.
    PubMed     Text format     Abstract available


  98. HERNANDEZ-OJEDA J, Arbelo E, Borras R, Berne P, et al
    Patients With Brugada Syndrome and Implanted Cardioverter-Defibrillators: Long-Term Follow-Up.
    J Am Coll Cardiol. 2017;70:1991-2002.
    PubMed     Text format     Abstract available


  99. BARON-ESQUIVIAS G, Morillo CA, Moya-Mitjans A, Martinez-Alday J, et al
    Dual-Chamber Pacing With Closed Loop Stimulation in Recurrent Reflex Vasovagal Syncope: The SPAIN Study.
    J Am Coll Cardiol. 2017;70:1720-1728.
    PubMed     Text format     Abstract available


    September 2017
  100. PAQUETTE M, Riou Franca L, Teutsch C, Diener HC, et al
    Persistence With Dabigatran Therapy at 2 Years in Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2017;70:1573-1583.
    PubMed     Text format     Abstract available


  101. NICHOL G, Sayre MR, Guerra F, Poole J, et al
    Defibrillation for Ventricular Fibrillation: A Shocking Update.
    J Am Coll Cardiol. 2017;70:1496-1509.
    PubMed     Text format     Abstract available


  102. PASTORI D, Nocella C, Farcomeni A, Bartimoccia S, et al
    Relationship of PCSK9 and Urinary Thromboxane Excretion to Cardiovascular Events in Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2017;70:1455-1462.
    PubMed     Text format     Abstract available


  103. BOCCHI EA, Bestetti RB, Scanavacca MI, Cunha Neto E, et al
    Chronic Chagas Heart Disease Management: From Etiology to Cardiomyopathy Treatment.
    J Am Coll Cardiol. 2017;70:1510-1524.
    PubMed     Text format     Abstract available


  104. DEBATY G, Labarere J, Frascone RJ, Wayne MA, et al
    Long-Term Prognostic Value of Gasping During Out-of-Hospital Cardiac Arrest.
    J Am Coll Cardiol. 2017;70:1467-1476.
    PubMed     Text format     Abstract available


  105. BLOOMGARDEN ZT, Kosiborod MN, Handelsman Y
    Concomitant Diabetes and Atrial Fibrillation: No Sugarcoating the Bittersweet Reality.
    J Am Coll Cardiol. 2017;70:1336-1338.
    PubMed     Text format    


  106. ECHOUFFO-TCHEUGUI JB, Shrader P, Thomas L, Gersh BJ, et al
    Care Patterns and Outcomes in Atrial Fibrillation Patients With and Without Diabetes: ORBIT-AF Registry.
    J Am Coll Cardiol. 2017;70:1325-1335.
    PubMed     Text format     Abstract available


  107. NAZARIAN S, Zghaib T
    Is Atrial Fibrillation a Necessary Component of the Thrombogenic Atrium?
    J Am Coll Cardiol. 2017;70:1322-1324.
    PubMed     Text format    


  108. KING JB, Azadani PN, Suksaranjit P, Bress AP, et al
    Left Atrial Fibrosis and Risk of Cerebrovascular and Cardiovascular Events in Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2017;70:1311-1321.
    PubMed     Text format     Abstract available


  109. ESCANDE W, Boveda S, Defaye P, Leclercq C, et al
    Outcomes in Guideline-Based Versus Off-Guideline Primary Prevention Implantable Cardioverter-Defibrillator Recipients.
    J Am Coll Cardiol. 2017;70:1302-1303.
    PubMed     Text format    


    August 2017
  110. DESIMONE CV, Graff-Radford J, El-Harasis MA, Rabinstein AA, et al
    Cerebral Amyloid Angiopathy: Diagnosis, Clinical Implications, and Management Strategies in Atrial Fibrillation.
    J Am Coll Cardiol. 2017;70:1173-1182.
    PubMed     Text format     Abstract available


  111. YANNOPOULOS D, Bartos JA, Raveendran G, Conterato M, et al
    Coronary Artery Disease in Patients With Out-of-Hospital Refractory Ventricular Fibrillation Cardiac Arrest.
    J Am Coll Cardiol. 2017;70:1109-1117.
    PubMed     Text format     Abstract available


  112. WAZNI O, Chung MK
    Catheter Ablation for Rate Controlled Atrial Fibrillation: New Horizon in Heart Failure Treatment.
    J Am Coll Cardiol. 2017 Aug 22. pii: S0735-1097(17)39348.
    PubMed     Text format    


  113. PRABHU S, Taylor AJ, Costello BT, Kaye DM, et al
    Catheter Ablation Versus Medical Rate control in Atrial Fibrillation and Systolic Dysfunction (CAMERA-MRI).
    J Am Coll Cardiol. 2017 Aug 22. pii: S0735-1097(17)39349.
    PubMed     Text format     Abstract available


  114. SILKA MJ, Bar-Cohen Y
    Prevalence of Atrial Fibrillation and Permanent Atrial Arrhythmias in Congenital Heart Disease: Sequel or Series?
    J Am Coll Cardiol. 2017;70:866-868.
    PubMed     Text format    


  115. LABOMBARDA F, Hamilton R, Shohoudi A, Aboulhosn J, et al
    Increasing Prevalence of Atrial Fibrillation and Permanent Atrial Arrhythmias in Congenital Heart Disease.
    J Am Coll Cardiol. 2017;70:857-865.
    PubMed     Text format     Abstract available


  116. POOLE JE, Prutkin JM
    Subcutaneous Implantable Cardioverter-Defibrillator Finding a Place in Sudden Cardiac Death Prevention: Emerging or Emerged?
    J Am Coll Cardiol. 2017;70:842-844.
    PubMed     Text format    


  117. BOERSMA L, Barr C, Knops R, Theuns D, et al
    Implant and Midterm Outcomes of the Subcutaneous Implantable Cardioverter-Defibrillator Registry: The EFFORTLESS Study.
    J Am Coll Cardiol. 2017;70:830-841.
    PubMed     Text format     Abstract available


  118. IWASAWA J, Koruth JS, Petru J, Dujka L, et al
    Temperature-Controlled Radiofrequency Ablation for Pulmonary Vein Isolation in Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2017;70:542-553.
    PubMed     Text format     Abstract available


    July 2017
  119. SCHWARTZ PJ, Dagradi F, Castelletti S
    Evolution in Managing Long QT Syndrome: From Registries to Centers of Excellence.
    J Am Coll Cardiol. 2017;70:463-465.
    PubMed     Text format    


  120. ROHATGI RK, Sugrue A, Bos JM, Cannon BC, et al
    Contemporary Outcomes in Patients With Long QT Syndrome.
    J Am Coll Cardiol. 2017;70:453-462.
    PubMed     Text format     Abstract available


  121. SEKI A, Ishikawa T, Daumy X, Mishima H, et al
    Progressive Atrial Conduction Defects Associated With Bone Malformation Caused by a Connexin-45 Mutation.
    J Am Coll Cardiol. 2017;70:358-370.
    PubMed     Text format     Abstract available


  122. WHANG W
    Opportunities to Improve Outcomes in Atrial Fibrillation: Provider Specialty and Beyond.
    J Am Coll Cardiol. 2017;70:87-88.
    PubMed     Text format    


  123. PERINO AC, Fan J, Schmitt SK, Askari M, et al
    Treating Specialty and Outcomes in Newly Diagnosed Atrial Fibrillation: From the TREAT-AF Study.
    J Am Coll Cardiol. 2017;70:78-86.
    PubMed     Text format     Abstract available


    June 2017
  124. MILLER MA, Palaniswamy C, Dukkipati SR, Balulad S, et al
    Subcutaneous Implantable Cardioverter-Defibrillator Implantation Without Defibrillation Testing.
    J Am Coll Cardiol. 2017;69:3118-3119.
    PubMed     Text format    


  125. VASEGHI M, Barwad P, Malavassi Corrales FJ, Tandri H, et al
    Cardiac Sympathetic Denervation for Refractory Ventricular Arrhythmias.
    J Am Coll Cardiol. 2017;69:3070-3080.
    PubMed     Text format     Abstract available


  126. VIJAYARAMAN P, Bordachar P, Ellenbogen KA
    The Continued Search for Physiological Pacing: Where Are We Now?
    J Am Coll Cardiol. 2017;69:3099-3114.
    PubMed     Text format     Abstract available


  127. HALPERIN JL
    Preventing Myocardial Infarction in Patients With Atrial Fibrillation: Another Piece of the Puzzle.
    J Am Coll Cardiol. 2017;69:2910-2912.
    PubMed     Text format    


  128. LEE CJ, Pallisgaard JL, Olesen JB, Carlson N, et al
    Antithrombotic Therapy and First Myocardial Infarction in Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2017;69:2901-2909.
    PubMed     Text format     Abstract available


  129. FILIPPATOS G, Farmakis D
    How to Use Beta-Blockers in Heart Failure With Reduced Ejection Fraction and Atrial Fibrillation.
    J Am Coll Cardiol. 2017;69:2897-2900.
    PubMed     Text format    


  130. YAO X, Shah ND, Sangaralingham LR, Gersh BJ, et al
    Non-Vitamin K Antagonist Oral Anticoagulant Dosing in Patients With Atrial Fibrillation and Renal Dysfunction.
    J Am Coll Cardiol. 2017;69:2779-2790.
    PubMed     Text format     Abstract available


    May 2017
  131. SOLOMON SD, Chatterjee NA
    Who Benefits From Implantable Cardioverter-Defibrillators?: Integrating Absolute, Proportional, and Competing Risk.
    J Am Coll Cardiol. 2017;69:2619-2621.
    PubMed     Text format    


  132. BILCHICK KC, Wang Y, Cheng A, Curtis JP, et al
    Seattle Heart Failure and Proportional Risk Models Predict Benefit From Implantable Cardioverter-Defibrillators.
    J Am Coll Cardiol. 2017;69:2606-2618.
    PubMed     Text format     Abstract available


  133. O'KEEFE JH, DiNicolantonio JJ
    Alcohol and Atrial Fibrillation: Mitigating the Risk.
    J Am Coll Cardiol. 2017;69:2578.
    PubMed     Text format    


  134. NATTEL S
    Atrial Fibrillation and Body Composition: Is it Fat or Lean That Ultimately Determines the Risk?
    J Am Coll Cardiol. 2017;69:2498-2501.
    PubMed     Text format    


  135. FENGER-GRON M, Overvad K, Tjonneland A, Frost L, et al
    Lean Body Mass Is the Predominant Anthropometric Risk Factor for Atrial Fibrillation.
    J Am Coll Cardiol. 2017;69:2488-2497.
    PubMed     Text format     Abstract available


  136. PETERSON ED, Pokorney SD
    New Treatment Options Fail to Close the Anticoagulation Gap in Atrial Fibrillation.
    J Am Coll Cardiol. 2017;69:2485-2487.
    PubMed     Text format    


  137. MARZEC LN, Wang J, Shah ND, Chan PS, et al
    Influence of Direct Oral Anticoagulants on Rates of Oral Anticoagulation for Atrial Fibrillation.
    J Am Coll Cardiol. 2017;69:2475-2484.
    PubMed     Text format     Abstract available


  138. DORKS M, Jobski K, Herget-Rosenthal S, Hoffmann F, et al
    Mortality and Acute Kidney Injury in Asians With Atrial Fibrillation Treated With Dabigatran or Warfarin.
    J Am Coll Cardiol. 2017;69:2471.
    PubMed     Text format    


  139. CHAN YH, Kuo CT
    Reply: Mortality and Acute Kidney Injury in Asians With Atrial Fibrillation Treated With Dabigatran or Warfarin.
    J Am Coll Cardiol. 2017;69:2471-2472.
    PubMed     Text format    


  140. MUELLER KAL, Heinzmann D, Klingel K, Fallier-Becker P, et al
    Histopathological and Immunological Characteristics of Tachycardia-Induced Cardiomyopathy.
    J Am Coll Cardiol. 2017;69:2160-2172.
    PubMed     Text format     Abstract available


  141. SANTANGELI P, Frankel DS, Tung R, Vaseghi M, et al
    Early Mortality After Catheter Ablation of Ventricular Tachycardia in Patients With Structural Heart Disease.
    J Am Coll Cardiol. 2017;69:2105-2115.
    PubMed     Text format     Abstract available


    April 2017
  142. HUCKER WJ, Hanley A, Ellinor PT
    Improving Atrial Fibrillation Therapy: Is There a Gene for That?
    J Am Coll Cardiol. 2017;69:2088-2095.
    PubMed     Text format     Abstract available


  143. SUNDARAM V, Sahadevan J, Waldo AL, Stukenborg GJ, et al
    Implantable Cardioverter-Defibrillators With Versus Without Resynchronization Therapy in Patients With a QRS Duration >180 ms.
    J Am Coll Cardiol. 2017;69:2026-2036.
    PubMed     Text format     Abstract available


  144. HOBBELT AH, Spronk HM, Crijns HJ, Ten Cate H, et al
    Prethrombotic State in Young Very Low-Risk Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2017;69:1990-1992.
    PubMed     Text format    


  145. DU X, Dong J, Ma C
    Is Atrial Fibrillation a Preventable Disease?
    J Am Coll Cardiol. 2017;69:1968-1982.
    PubMed     Text format     Abstract available


  146. LORBERBAUM T, Tatonetti NP
    Reply: Combination Therapy With Ceftriaxone and Lansoprazole, Acquired Long QT Syndrome and Torsades de Pointes Risk.
    J Am Coll Cardiol. 2017;69:1877-1878.
    PubMed     Text format    


  147. LAZZERINI PE, Bertolozzi I, Rossi M, Capecchi PL, et al
    Combination Therapy With Ceftriaxone and Lansoprazole, Acquired Long QT Syndrome, and Torsades de Pointes Risk.
    J Am Coll Cardiol. 2017;69:1876-1877.
    PubMed     Text format    


  148. SANTANGELI P, Rame JE, Birati EY, Marchlinski FE, et al
    Management of Ventricular Arrhythmias in Patients With Advanced Heart Failure.
    J Am Coll Cardiol. 2017;69:1842-1860.
    PubMed     Text format     Abstract available


  149. DRIESSEN AH, Berger WR, Chan Pin Yin DR, Piersma FR, et al
    Electrophysiologically Guided Thoracoscopic Surgery for Advanced Atrial Fibrillation: 5-Year Follow-up.
    J Am Coll Cardiol. 2017;69:1753-1754.
    PubMed     Text format    


  150. FLETCHER G
    Atrial Fibrillation: A Threat to the Failing Heart?
    J Am Coll Cardiol. 2017;69:1692-1693.
    PubMed     Text format    


  151. LUO N, Merrill P, Parikh KS, Whellan DJ, et al
    Exercise Training in Patients With Chronic Heart Failure and Atrial Fibrillation.
    J Am Coll Cardiol. 2017;69:1683-1691.
    PubMed     Text format     Abstract available


    March 2017
  152. DE CATERINA R, Renda G, Carnicelli AP, Nordio F, et al
    Valvular Heart Disease Patients on Edoxaban or Warfarin in the ENGAGE AF-TIMI 48 Trial.
    J Am Coll Cardiol. 2017;69:1372-1382.
    PubMed     Text format     Abstract available


    February 2017
  153. SHARMA S, Drezner JA, Baggish A, Papadakis M, et al
    International Recommendations for Electrocardiographic Interpretation in Athletes.
    J Am Coll Cardiol. 2017;69:1057-1075.
    PubMed     Text format     Abstract available


  154. HUISMAN MV, Rothman KJ, Paquette M, Teutsch C, et al
    The Changing Landscape for Stroke Prevention in AF: Findings From the GLORIA-AF Registry Phase 2.
    J Am Coll Cardiol. 2017;69:777-785.
    PubMed     Text format     Abstract available


  155. VADUGANATHAN M, Patel RB, Michel A, Shah SJ, et al
    Mode of Death in Heart Failure With Preserved Ejection Fraction.
    J Am Coll Cardiol. 2017;69:556-569.
    PubMed     Text format     Abstract available


  156. VENLET J, Piers SR, Jongbloed JD, Androulakis AF, et al
    Isolated Subepicardial Right Ventricular Outflow Tract Scar in Athletes With Ventricular Tachycardia.
    J Am Coll Cardiol. 2017;69:497-507.
    PubMed     Text format     Abstract available


    January 2017
  157. VAL-BLASCO A, Piedras MJ, Ruiz-Hurtado G, Suarez N, et al
    Role of NOD1 in Heart Failure Progression via Regulation of Ca2+ Handling.
    J Am Coll Cardiol. 2017;69:423-433.
    PubMed     Text format     Abstract available


  158. SEITZ J, Bars C, Theodore G, Beurtheret S, et al
    AF Ablation Guided by Spatiotemporal Electrogram Dispersion Without Pulmonary Vein Isolation: A Wholly Patient-Tailored Approach.
    J Am Coll Cardiol. 2017;69:303-321.
    PubMed     Text format     Abstract available


  159. MADHAVAN M, Mulpuru SK, McLeod CJ, Cha YM, et al
    Advances and Future Directions in Cardiac Pacemakers: Part 2 of a 2-Part Series.
    J Am Coll Cardiol. 2017;69:211-235.
    PubMed     Text format     Abstract available


  160. MULPURU SK, Madhavan M, McLeod CJ, Cha YM, et al
    Cardiac Pacemakers: Function, Troubleshooting, and Management: Part 1 of a 2-Part Series.
    J Am Coll Cardiol. 2017;69:189-210.
    PubMed     Text format     Abstract available


    August 2016
  161. PARASHAR A, Sud K, Devgun J, Agarwal S, et al
    Feasibility of LAA Closure for Left Atrial Thrombus in Patients With Aortic Stenosis and AF.
    J Am Coll Cardiol. 2016;68:770-1.
    PubMed     Text format    


    May 2016
  162. SINNECKER D, Dommasch M, Steger A, Berkefeld A, et al
    Expiration-Triggered Sinus Arrhythmia Predicts Outcome in Survivors of Acute Myocardial Infarction.
    J Am Coll Cardiol. 2016;67:2213-20.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Arrhythmias is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: